Algorithmiq
Quantum algorithms for drug discovery
About
Founded in 2020, Algorithmiq develops advanced quantum algorithms tailored for chemistry and life science applications, specifically quantum drug discovery software. The company operates on a SaaS model delivering software platforms that enable researchers to simulate molecular properties and accelerate drug development using quantum computing. Headquartered in Milan, Italy, after relocating from Helsinki, Algorithmiq has raised substantial funding, signaling strong investor confidence in quantum software for healthcare life sciences.
Products
- Quantum Drug Discovery Software
- Quantum Chemistry Simulation Platform
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Algorithmiq — available to members.
